Search Results - "ZELINKOVA, Z."

Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety by de Lima, A, Zelinkova, Z, van der Ent, C, Steegers, E A P, van der Woude, C J

“…Antitumour necrosis factor (TNF) during pregnancy in patients with IBD is related to high fetal anti-TNF levels. We evaluated maternal and child safety on…”
Get more information

The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease by van der Woude, C.J., Ardizzone, S., Bengtson, M.B., Fiorino, G., Fraser, G., Katsanos, K., Kolacek, S., Juillerat, P., Mulders, A.G.M.G.J., Pedersen, N., Selinger, C., Sebastian, S., Sturm, A., Zelinkova, Z., Magro, F.

“…Trying to conceive and being pregnant is an emotional period for those involved. In the majority of patients suffering from inflammatory bowel disease,…”
Get full text

Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease by WEST, R. L., ZELINKOVA, Z., WOLBINK, G. J., KUIPERS, E. J., STOKKERS, P. C. F., VAN DER WOUDE, C. J.

“…Summary Background  Adalimumab is an effective treatment in patients with Crohn’s disease; as it is a humanized anti‐tumour necrosis factor monoclonal…”
Get full text

Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients by Bultman, E., de Haar, C., van Liere-Baron, A., Verhoog, H., West, R. L., Kuipers, E. J., Zelinkova, Z., Janneke van der Woude, C.

“…Summary Background  Adalimumab is effective for the induction and maintenance of remission in Crohn’s disease (CD)‐patients. Aim  To find predictors for…”
Get full text

High intra‐uterine exposure to infliximab following maternal anti‐TNF treatment during pregnancy by Zelinkova, Z., de Haar, C., de Ridder, L., Pierik, M. J., Kuipers, E. J., Peppelenbosch, M. P., van der Woude, C. J.

“…Aliment Pharmacol Ther 2011; 33: 1053–1058 Summary Background  Typically, inflammatory bowel disease (IBD) patients are in their reproductive years, raising…”
Get full text

Adalimumab in Crohn's disease patients: pharmacokinetics in the first 6 months of treatment by Lie, M. R. K. L., Peppelenbosch, M. P., West, R. L., Zelinkova, Z., Woude, C. J.

“…Summary Background Adalimumab is an effective therapy for Crohn's disease patients. However, there is limited knowledge on the pharmacokinetic properties of…”
Get full text

A Prospective Study of the Safety of Lower Gastrointestinal Endoscopy During Pregnancy in Patients with Inflammatory Bowel Disease by de Lima, A., Zelinkova, Z., van der Woude, C. J.

“…Introduction: Women with inflammatory bowel disease [IBD] have a higher risk of undergoing gastrointestinal [GI] endoscopy during pregnancy than healthy women…”
Get full text

Azathioprine treatment during lactation by Zelinkova, Z., De Boer, I. P., Van Dijke, M. J., Kuipers, E. J., Van Der Woude, C. J.

Get full text

High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study by BAARS, J. E., ZELINKOVA, Z., MENSINK, P. B. F., MARKUS, T., LOOMAN, C. W. N., KUIPERS, E. J., VAN DER WOUDE, C. J.

“…Aliment Pharmacol Ther 30, 864–872 Summary Background  Adherence is important for successful treatment in inflammatory bowel disease (IBD) patients. Previous…”
Get full text

3-Chloropropane-1,2-diol fatty acid esters in potato products by Ilko, V.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Chemie a Analyzy Potravin, Zelinkova, Z.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Chemie a Analyzy Potravin, Dolezal, M.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Chemie a Analyzy Potravin, Velisek, J.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Chemie a Analyzy Potravin

“…The levels of 3-chloropropane-1,2-diol (3-CPD) and fatty acid esters in raw potatoes, potato flakes, instant mashed potatoes, 2 potato dumplings, 32 French…”
Get full text

Formation of acylglycerol chloro derivatives in vegetable oils and mitigation strategy by Smidrkal, J.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Technologie Mleka a Tuku, Ilko, V.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Chemie a Analyzy Potravin, Filip, V.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Technologie Mleka a Tuku, Dolezal, M.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Chemie a Analyzy Potravin, Zelinkova, Z.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Chemie a Analyzy Potravin, Kyselka, J.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Technologie Mleka a Tuku, Hradkova, I.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Technologie Mleka a Tuku, Velisek, J.,Vysoka Skola Chemicko-technologicka, Prague (Czech Republic). Ustav Chemie a Analyzy Potravin

“…The most important acylglycerol chloroderivatives identified in foods are 3-chlorpropane-1,2-diol fatty acid esters (3-CPD esters). They are accompanied by…”
Get full text

P528 Effectiveness, Safety and Incremental Costs of Proactive Therapeutic Drug Monitoring of Infliximab in a Prospective Cohort of Inflammatory Bowel Disease Patients by Zelinkova, Z, Podmanicky, D, Kadleckova, B

“…Abstract Background The use of infliximab (IFX) is limited by low treatment persistence. Proactive therapeutic drug monitoring (pTDM) has been shown to…”
Get full text

Occurrence of 3-MCPD fatty acid esters in human breast milk by Zelinková, Z., Novotný, O., Schůrek, J., Velíšek, J., Hajšlová, J., Doležal, M.

“…A series of twelve breast milk samples were analysed by gas chromatography-mass spectrometry (GC/MS) operated in selected ion monitoring mode for…”
Get full text

P392 Behaviour of Childhood-onset Inflammatory Bowel Disease through Adulthood by Zelinkova, Z, Kadleckova, B, Cierna, I, Podmanicky, D

“…Abstract Background The incidence of childhood-onset inflammatory bowel disease (IBD) is rising but the data on the behaviour of the disease during the…”
Get full text

Impact of the growth hormone replacement on bone status in growth hormone deficient adults by Kužma, M, Kužmová, Z, Zelinková, Z, Killinger, Z, Vaňuga, P, Lazurová, I, Tomková, S, Payer, J

“…Abstract Introduction Growth hormone deficiency (GHD) is associated with reduced bone mineral density (BMD). GH replacement has positive effect on BMD but the…”
Get full text

P461 Vedolizumab Dose Escalation in a Real-World Cohort of IBD Patients by Zelinkova, Z, Kadleckova, B, Lucenicova, J

“…Abstract Background Vedolizumab (VDZ) effectively induces and maintains remission in inflammatory bowel disease (IBD). The loss of response to VDZ has been…”
Get full text

P655 MadCAM1 Negativity of Lamina Propria Endothelial Cells is Associated with Non-Response to Vedolizumab in Inflammatory Bowel Disease Patients by Zelinkova, Z, Podmanicky, D, Berakova, K, Kadleckova, B

“…Abstract Background Vedolizumab (VDZ), a monoclonal antibody against α4β7 integrin has been shown to be effective in inducing and maintaining remission in…”
Get full text

P512 Vedolizumab is effective in the prevention and treatment of postoperative recurrence in patients with Crohn′s disease by Kadleckova, B, Podmanicky, D, Lipovska, A, Zelinkova, Z

“…Abstract Background Vedolizumab (VDZ), an anti-integrin monoclonal antibody has demonstrated its efficacy in inducing and maintaining response in patients with…”
Get full text

NOD2 in Crohn's disease--loss or gain of function mutations? by Zelinkova, Z, Stokkers, P, Hommes, D W

Get full text

P470 Ustekinumab Trough Levels are not Associated with Clinical Response in Inflammatory Bowel Disease Patients by Zelinkova, Z, Lipovska, A, Otottova, K, Lucenicova, J, Kadleckova, B

“…Abstract Background Ustekinumab (UST) has been shown to effectively induce and maintain remission in inflammatory bowel disease (IBD). Only a few studies thus…”
Get full text